Mounjaro becomes India’s top-selling drug as patients shift to GLP-1 injections

Tuesday, September 8, 2026 - 11:10
0 1
Mounjaro becomes India’s top-selling drug as patients shift to GLP-1 injections
Mounjaro recorded sales of ₹1,256 crore in the 12 months ending August 2026, up 502 per cent from the previous year

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Comments (0)

User